申请人:Smaill Jeffrey Bruce
公开号:US20150299230A1
公开(公告)日:2015-10-22
The invention relates to compounds of use as targeted cytotoxic agents and methods of use thereof. In particular, the invention relates to prodrugs that are substantially resistant to human AKR1C3 enzyme metabolism, methods of cell ablation using said compounds and methods of treatment of cancer and other hyperproliferative disorders using said compounds.
该发明涉及用作靶向细胞毒性剂的化合物及其使用方法。特别是,该发明涉及对人类AKR1C3酶代谢具有相当抵抗力的前药、使用该化合物进行细胞消融的方法,以及使用该化合物治疗癌症和其他过度增殖性疾病的方法。